Nanoliposomes in Cancer Therapy: Marketed Products and Current Clinical Trials.

ABSTRACT: The drugs used for cancer treatment have many drawbacks, as they damage both tumor and healthy cells and, in addition, they tend to be poorly soluble drugs. Their transport in nanoparticles can solve these problems as these can release the drug into tumor tissues, as well as improve their solubility, bioavailability, and efficacy, reducing their adverse effects. This article focuses on the advantages that nanotechnology can bring to medicine, with special emphasis on nanoliposomes. For this, a review has been made of the nanoliposomal systems marketed for the treatment of cancer, as well as those that are in the research phase, highlighting the clinical trials being carried out. All marketed liposomes studied are intravenously administered, showing a reduced intensity of side-effects compa

SUBMITTER: Talens-Visconti R 

PROVIDER: S-EPMC9030431 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature